Aashka Hospitals Board of Directors

Get the latest insights into the leadership at Aashka Hospitals. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Bipinchandra ShahChairman & Managing Director
Shreyarthi ShahNon Executive Director
Umang ShahNon Executive Independent Director
Mayank AgarwalCompany Secretary & Compliance Officer
Jigar Kanakchandra TrivediNon Executive Independent Director

Aashka Hospitals Share price

AASHKA

67

0.00 (0.00%)
Last updated on 24 Apr, 2026 | 16:00 IST
Today's High

00

Today's Low

00

52 Week Low

59.00

52 Week High

107.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Aashka Hospitals FAQs

The board at Aashka Hospitals consists of experienced professionals, including Bipinchandra Shah, Shreyarthi Shah, and others, overseeing the company’s strategic and corporate governance.

Directors at Aashka Hospitals are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Bipinchandra Shah is the current chairman at Aashka Hospitals.

Executive directors at Aashka Hospitals are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Aashka Hospitals adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Aashka Hospitals, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost